Total lesion glycolysis is a promising predictor of chemo‐response in pancreatic cancer patients treated with neoadjuvant chemotherapy prior to surgery
TLG was shown to be a superior predictor of chemo-response and patient prognosis compared to all other FDG-PET/CT parameters in PDAC patients treated with NAC.
Authors
- Sarah Maloney (ORCID: https://orcid.org/0000-0001-9333-2490)
- Angela S. Y. Chou (ORCID: https://orcid.org/0000-0001-9212-6927)
- Jaswinder Singh Samra (ORCID: https://orcid.org/0000-0001-6664-7147)
- Anthony James Gill (ORCID: https://orcid.org/0000-0002-9447-1967)
- Sooin Byeon
- Anubhav Mittal (ORCID: https://orcid.org/0000-0003-3960-2968)
- Sumit Sahni (ORCID: https://orcid.org/0000-0002-2900-8845)
- PAUL J. ROACH (ORCID: https://orcid.org/0000-0003-2504-0474)
- Dale L. Bailey (ORCID: https://orcid.org/0000-0001-9154-7957)
- B. J. Abbott
Institutions
- The University of Sydney (AU)
- Royal North Shore Hospital (AU)
- Northern Sydney Local Health District (AU)
- The University of Notre Dame Australia (AU)
Publication Details
- Journal
- European Journal of Clinical Investigation
- Published
- 2025-04-08
- DOI
- https://doi.org/10.1111/eci.70046
- Citations
- 1
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- NSW Health Pathology
- University of Sydney